Marty Felsenthal has spent his career working with emerging growth health care services and health care information technology companies, initially as an investment banker at Alex, Brown & Sons, and, since 1997, as a venture investor focused on health care services and health care information technology companies. Marty led financings and serves on the boards of Teladoc, OnShift, and Vericare. Previously, Marty served on the boards of Change Healthcare (acquired by Emdeon), Aperio (acquired by Danaher), Titan Health (acquired by United Surgical Partners), U.S. Renal Care (acquired by Leonard Green), and PayerPath (acquired by Misys/Allscripts). As an investor, Marty has recruited more than 50 executives to the portfolio companies with whom he has partnered and has initiated many significant customer relationships. Marty received a BA from Princeton University and an MBA from the Stanford University Graduate School of Business.
